Masaharu Higashida Selected Research

Masaharu Higashida Research Topics

11	Stomach Neoplasms (Stomach Cancer) 01/2022 - 06/2007
9	Esophageal Neoplasms (Esophageal Cancer) 04/2021 - 12/2006
9	Neoplasms (Cancer) 10/2020 - 10/2013
7	Neoplasm Metastasis (Metastasis) 12/2021 - 11/2008
3	Lymphatic Metastasis 12/2021 - 12/2019
2	Neuroendocrine Carcinoma 12/2021 - 04/2020
2	Acute Cholecystitis 03/2021 - 03/2016
2	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 11/2015
2	Carcinoma (Carcinomatosis) 10/2013 - 05/2012
1	Residual Neoplasm 01/2022
1	Postoperative Hemorrhage 04/2021
1	Lung Diseases (Lung Disease) 10/2020
1	Lung Neoplasms (Lung Cancer) 10/2020
1	Margins of Excision 10/2020
1	Anorexia 03/2020
1	Rectal Neoplasms (Rectal Cancer) 01/2020
1	Esophageal Squamous Cell Carcinoma 06/2019
1	Cholecystitis 03/2016
1	Acalculous Cholecystitis 03/2016
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2014
1	Leukopenia 05/2012
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 11/2008
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 12/2006
1	Purpura 08/2006

6	Docetaxel (Taxotere)FDA Link 01/2017 - 12/2006
5	Fluorouracil (Carac)FDA LinkGeneric 01/2017 - 12/2006
3	titanium silicide (TS-1)IBA 01/2017 - 11/2012
2	Carboplatin (JM8)FDA LinkGeneric 12/2021 - 04/2020
2	Eicosapentaenoic AcidIBA 01/2017 - 10/2013
2	nedaplatinIBA 05/2012 - 05/2007
1	vasectrin I (VS I)IBA 01/2022
1	4-azidosalicylic acid-phosphatidylserineIBA 01/2022
1	Etoposide (VP 16)FDA LinkGeneric 12/2021
1	C-Reactive ProteinIBA 04/2021
1	Immunologic Factors (Immunomodulators)IBA 04/2021
1	NivolumabIBA 10/2020
1	Trastuzumab (Herceptin)FDA Link 12/2019
1	S-1 plus cisplatinIBA 12/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2017
1	Cisplatin (Platino)FDA LinkGeneric 01/2017
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2017
1	PotassiumIBA 07/2014
1	TegafurIBA 07/2014
1	Interleukin-6 (Interleukin 6)IBA 10/2013
1	CytokinesIBA 10/2013
1	NF-kappa B (NF-kB)IBA 10/2013
1	Imatinib Mesylate (Gleevec)FDA Link 11/2008
1	Factor XIII (Coagulation Factor XIII)IBA 08/2006

11	Drug Therapy (Chemotherapy) 05/2021 - 05/2007
7	Gastrectomy 01/2022 - 03/2017
5	Therapeutics 12/2021 - 12/2006
3	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 03/2020
3	Chemoradiotherapy 06/2019 - 05/2007
2	Esophagectomy 04/2021 - 08/2017
2	Laparoscopic Cholecystectomy 03/2021 - 03/2016
2	Neoadjuvant Therapy 01/2020 - 06/2019
2	Adjuvant Chemotherapy 11/2012 - 06/2007
2	Combination Drug Therapy (Combination Chemotherapy) 05/2012 - 05/2007
2	Radiotherapy 05/2012 - 11/2009
1	Cholecystectomy 03/2020
1	Self Expandable Metallic Stents 01/2019
1	Decompression 01/2019
1	Stents 01/2019
1	Induction Chemotherapy 12/2018
1	Perioperative Period 08/2017
1	Oral Administration 06/2007